Understanding Tumor Evolution with Single-Cell Transcriptomics
Author Information
Author(s): Patrick A. Cosgrove, Andrea H. Bild, Thanh H. Dellinger, Behnam Badie, Jana Portnow, Aritro Nath
Primary Institution: City of Hope National Medical Center
Hypothesis
How does tumor heterogeneity impact tumor evolution and therapy response?
Conclusion
Single-cell RNA sequencing provides insights into tumor heterogeneity and can improve treatment strategies.
Supporting Evidence
- Single-cell RNA sequencing allows for detailed analysis of tumor heterogeneity.
- Understanding tumor evolution can lead to improved patient outcomes.
- Collaborative approaches are necessary for effective implementation of single-cell genomics in clinical trials.
Takeaway
This study looks at how cancer cells are different from each other and how that affects treatment. By studying individual cells, doctors can find better ways to help patients.
Methodology
The study utilized single-cell RNA sequencing to analyze tumor samples from patients in clinical trials.
Potential Biases
Potential biases in sample collection and processing methods.
Limitations
Challenges include obtaining high-quality cells and technical variability in single-cell sequencing.
Participant Demographics
Patients with breast, brain, and ovarian cancers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website